SSPE (Subacute Sclerosing Panencephalitis ? is a fatal form of progressive brain inflammation caused by persistent infection with the measles virus. It primarily affects children, teenagers, and young adults. It is important to note that SSPE is caused by the wild-type measles virus and not by vaccine strains. This condition is a severe, fatal post-measles complication.
Symptoms of SSPE include:
• A history of measles infection followed by an asymptomatic period, which typically lasts around 7 years.
• Progressive neurological deterioration, which manifests as behavior changes, intellectual decline, myoclonic seizures, blindness, and ataxia.
• Further progression leads to loss of consciousness, a vegetative state, paralysis, and disturbances in vital functions (breathing, heart rate, and blood pressure), ultimately resulting in death.
Currently there is no treatment or vaccine to this. I would like to know are there any children’s or families with this conditions.. I want to connect with that family and understand how are they managing ?
Photo Courtesy – Downloaded from https://www.infectiousdiseaseadvisor.com/
Unfortunately there is currently no curative treatment. Only supportive measures to improve the quality of life of patients. As anticonvulsants or pain treatments. Some antivirals have been tried, but without success.
The most important thing to prevent this disease from happening is adequate vaccination. Currently in Argentina, cases of measles are reappearing and this is due to imported cases from people who traveled to countries where vaccination rates are low, either due to health problems or anti-vaccine movements. We must have our children’s calendar and our own calendar properly updated.
Thank you Valeria, Do you have any Protocol or Management Guidelines for SSPE. We have hundreds of patients in India
I don’t have a specially protocol, I had an only patient when I was resident. But I remember that we used the guidelines on PUBMED. I’ll search this for you and I’ll sent you!
These are two interesting articles!
DOI: 10.1007/s11940-022-00710-x
DOI: 10.3390/molecules26020427
Thank you. I will go through this.